This article is more than 5 years old. Information may no longer be current.
Tisch Cancer Institute appoints director of Center for Carcinoid and Neuroendocrine Tumors
Click Here to Manage Email Alerts
Edward M. Wolin, MD, has been appointed director of the Center for Carcinoid and Neuroendocrine Tumors at Mount Sinai Health System’s Tisch Cancer Institute.
Wolin also will serve as professor of medicine at Icahn School of Medicine at Mount Sinai.
“We are very excited about Dr. Wolin joining The Tisch Cancer Institute. With his remarkable expertise and research experience, Dr. Wolin will lead Mount Sinai’s program to a new level of prominence,” William K. Oh, MD, chief of hematology and medical oncology for Mount Sinai Health System, and associate director for clinical and translational research and deputy director of Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai, said in a press release. “We look forward to advancing our program, which is one of the only neuroendocrine tumor centers in the country, and providing optimal care for patients from around the world.”
Wolin most recently served as director of the neuroendocrine tumor program at Montefiore Einstein Center for Cancer Care. He previously served as director of neuroendocrine tumor programs at University of Kentucky Medical Center and Cedars-Sinai Medical Center.
He has helped to pioneer innovative therapies with novel somatostatin analogs, anti-angiogenic drugs, mTOR inhibitors and peptide receptor radiotherapy.
“The Center for Carcinoid and Neuroendocrine Tumors at Mount Sinai is an international destination for patients looking for expertise in this type of cancer, and I am honored to become the director of this multidisciplinary program,” Wolin said in the release. “We have tremendous surgeons, gastroenterologists, radiologists, nuclear medicine doctors, cardiologists and other specialists who all work together to treat these complex cancers. As a medical oncologist specializing in these tumors, I will bring new therapies and coordinate care to help bring the program to the next level.”